51005-25-5|Aspirin mixture with Butalbital and Caffeine|2-acetoxybenzoic acid compound with 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione and 5-allyl-5-isobutylpyrimidine-2,4,6(1H,3H,5H)-trione (111)|-范德生物科技公司

Aspirin mixture with Butalbital and Caffeine

NMR下载 COA and HPLC MSDS下载
names：
2-acetoxybenzoic acid compound with 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione and 5-allyl-5-isobutylpyrimidine-2,4,6(1H,3H,5H)-trione (111)
CAS号：
51005-25-5
MDL Number：
MF(分子式)： C28H34N6O9 MW(分子量)： 598.61
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Aspirin mixture with Butalbital and Caffeine
英文别名	Aspirin mixture with Butalbital and Caffeine; Axotal; Butal Compound; Butalbital aspirin and caffeine
CAS号	51005-25-5
SMILES	CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C.CC(=O)Oc1ccccc1C(=O)O.Cn1cnc2c1c(=O)n(c(=O)n2C)C
Inchi	InChI=1S/C11H16N2O3.C9H8O4.C8H10N4O2/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15;1-6(10)13-8-5-3-2-4-7(8)9(11)12;1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16);2-5H,1H3,(H,11,12);4H,1-3H3
InchiKey	YTPUIQCGRWDPTM-UHFFFAOYSA-N
分子式 Formula	C28H34N6O9
分子量 Molecular Weight	598.61
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Aspirin mixture with Butalbital and Caffeine(CAS:51005-25-5):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	This product has been discontinued (DEA controlled substance). Aspirin mixture with Butalbital and Caffeine is combination drug of butalbital, caffeine and aspirin.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501481/ PubMed PMID: 30000541.

[2]Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501467/ PubMed PMID: 30000527.

[3] Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501196/ PubMed PMID: 30000255.

[4] Poyant JO, Albright R, Clain J, Pandompatam G, Barreto EF. Extracorporeal elimination of butalbital in acute aspirin-butalbital-caffeine-codeine (Fiorinal with Codeine) poisoning. Clin Toxicol (Phila). 2018 Jun;56(6):439-441. doi: 10.1080/15563650.2017.1400554. Epub 2017 Nov 10. PubMed PMID: 29124988.

[5] Yeakel JK, Logan BK. Butalbital and driving impairment. J Forensic Sci. 2013 Jul;58(4):941-5. doi: 10.1111/1556-4029.12143. Epub 2013 May 17. PubMed PMID: 23682958.

6: Sohn RS. Comparison of stadol NS and fiorinal with codeine. Headache. 1999 Feb;39(2):137-8. PubMed PMID: 18564449.7: Woodside DB, Colton P, Staab R, Schreiber M, Sutandar-Pinnock K, Poynter B, Sacevich T. Weight restoration in a patient with anorexia nervosa on dialysis. Int J Eat Disord. 2005 Dec;38(4):380-2. PubMed PMID: 16261601.8: Martin VT, Loder E, Taylor K, Almas M, Hilliard B. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. Cephalalgia. 2005 Sep;25(9):726-34. PubMed PMID: 16109055.9: Goldstein J, Gawel MJ, Winner P, Diamond S, Reich L, Davidson WJ, Sussman NM. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine. Headache. 1998 Jul-Aug;38(7):516-22. PubMed PMID: 15613167.10: Meatherall R. GC/MS confirmation of barbiturates in blood and urine. J Forensic Sci. 1997 Nov;42(6):1160-70. PubMed PMID: 9397563.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开